Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.583 | Clinical features and Treatment outcomes in Paediatric probable antibody-negative autoimmune encephalitis in Hong Kong | Dr. YAM Karen Kwan Ming |
| 2011.009 | A Cross-sectional Study on Specific Upper Limb Muscle Activities and Fatigue Pattern after simulated Game with Electromyography and Synchronized Video Capture for Boccia Athletes | Ms Yam Kit Yee |
| 2024.049 | Review of efficacy and safety of MEK inhibitor for treatment of neurofibromatosis Type 1 (NF1)-associated plexiform neurofibroma (PN) in Hong Kong |
Dr. YAM Kwan Ming 任君明 |
| 2016.521 | Evaluation of the association of electroencephalogram (EEG) patterns with mortality in patients with altered mental state |
Dr. YAM Kwan Ming 任君明 |
| 2013.563 | Left ventricular mass and clinical characteristics of persistent masked hypertension in Hong Kong youth - a community cohort study | Dr Yam Man Ching |
| 2010.003 | Novel care pathway for managing patients with acute urinary retention in the emergency medicine ward: a retrospective study | Ms YAM Shuk Fong Estella |
| 2010.343 | Difficulties, satisfaction, and coping strategies of the family caregivers of stroke survivors | Miss YAM Yim Ling |
| 2009.167 | Chinese Translation and Validation of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease | Prof. YAN Bryan |
| 2010.595 | Hong Kong Cardiovascular Health Survey: Awareness & Knowledge of Cardiovascular Risk & Cardiovascular Risk Reduction Behaviour | Prof Yan Bryan |
| 2009.041 | Efficacy, Safety and Cost-Effectiveness of Drug-eluting Stents in “Real World” Hong Kong Cardiology Practice | Dr. YAN Bryan |
| 2015.538 | A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 |
Prof. YAN Bryan 甄秉言教授 |
| 2013.351 | Effect of Heparin on Radial Artery Occlusion After Transradial Artery Catheterization for Coronary Angiography. | Professor YAN Bryan |
| 2011.053 | Efficacy, Safety and cost-effectiveness of anti-proliferative treatment of coronary arteries with catheter-based delivery of fluid paclitaxel after bare-metal stenting to reduce restenosis in high-risk patients: A multicenter randomized controlled study | Prof Yan Bryan |
| 2017.695 | Validation of a new non-invasive oscillometric device for capillary blood pressure measurement |
Dr. YAN Bryan 甄秉言 |
| 2019.571 | Gaps In Awareness of Peripheral Arterial Disease in Hong Kong: A Cross Sectional Study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2020.448 | Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomized, Open-label study |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2018.393 | Validation of a cuffless blood pressure device for 24-hours ambulatory blood pressure monitoring |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2018.442 | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2020.080 | A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2019.004 | Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2018.382 | ILUMIEN IV: OPTIMAL PCI OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2020.082 | A Non-randomized, Clinical Registry of the DynamX Novolimus Eluting Coronary Bioadaptor System in the Treatment of Patients with De Novo Native Coronary Artery Lesions |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2019.357 | Prolonged Ambulatory Heart Rate Variability Monitoring to Predict Major Adverse Cardiac Events in High-risk Patients with Cardiovascular Diseases |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2019.021 | Activation Pattern and Acute Hemodynamics of His and Left Bundle Pacing | Prof. YAN Bryan Ping Yen |
| 2018.214 | XIENCE 28 Global Study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2020.154 | BIOFLOW-DAPT: BIOTRONIK – A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual AntiPlatelet Therapy |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2019.346 | HD Mapping Observational Study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2018.299 | Lipid management status of patients with ischemic stroke (IS) in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2018.215 | Electrical Activation Mapping Guided Cardiac Resynchronization Therapy for Nonresponders | Prof. YAN Bryan Ping Yen |
| 2018.068 | A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A randomized controlled trial | Prof. YAN Bryan Ping Yen |
| 2018.304 | Achievement of cardiovascular risk factor goals and target levels in patients at very-high and high cardiovascular risk in Hong Kong |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2019.653 | In-Depth Analyses of 12-lead ECG P-wave Indices Using Machine Learning to Predict Atrial Fibrillation and Cardiovascular Events |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.332 | A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting. (RE-DUAL PCI) | Prof. YAN Bryan Ping Yen |
| 2014.210 | Randomized controlled trial and cost-effectiveness analysis of targeted rapid screening for atrial fibrillation using a handheld single-lead ECG device with automated diagnostics and tailored stroke prevention strategy for screen-detected patients | Prof. YAN Bryan Ping Yen |
| 2010.440 | A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction | Prof. YAN Bryan Ping Yen |
| 2011.178 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Prof. YAN Bryan Ping Yen |
| 2013.420 | Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension | Prof. YAN Bryan Ping Yen |
| 2009.531 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia | Prof. Yan Bryan Ping Yen |
| 2012.561 | Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Prof. YAN Bryan Ping Yen |
| 2013.658 | A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS | Prof. YAN Bryan Ping Yen |
| 2013.586 | GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) | Prof. YAN Bryan Ping Yen |
| 2011.534 | Type D personality in patients contemplating coronary revascularization | Prof. YAN Bryan Ping Yen |
| 2024.339 | Investigations of cardiotoxicity in cancer survivors | Prof. YAN Bryan Ping Yen |
| 2024.212 | Retrospective Database Study for Treatment Patterns of Lipid-lowering Therapy in Patients with Hypercholesterolemia or Mixed Dyslipidemia in Hong Kong and South Korea (READY Study) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.251 | BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (Freesolve) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A randomized controlled trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.443 | Risk Factors for Blood Pressure Variability in Patients with Cardiovascular Disease: a Longitudinal Telemonitoring Cohort Study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.156 | A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.152 | Rationale and design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.650 | A randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes: Victorion – RIDES |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.577 | Switching Sildenafil to Riociguat in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) | Prof. YAN Bryan Ping Yen |
Page 269 of 289.

